The New York attorney general’s office is asking the Food and Drug Administration (FDA) to double down on its warnings and discourage the use of an asthma drug. “The New York Office of the Attorney General writes to encourage the FDA to address the dangers of montelukast, particularly to the most vulnerable population—minor children—and protect… Source
Related posts:
Bahraini uprising to continue until all demands are met: Opposition figure
Stockholm schools send pupils home amid warnings of overstretched intensive care wards due to Covid-...
UK funded company with $1m to discourage Afghans from migrating, report reveals
Cost of making western Mosul ‘liveable’ double previous estimates, UN warns
Journalist Jailed By Israel Approaches 70th Day Of Hunger Strike
COVID-19: Indian variant cases double in UK to nearly 7,000 in just a week
Views: 0